RARE
Price
$35.13
Change
-$0.24 (-0.68%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
3.3B
28 days until earnings call
RVMD
Price
$32.88
Change
-$1.72 (-4.97%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
6.43B
39 days until earnings call
Ad is loading...

RARE vs RVMD

Header iconRARE vs RVMD Comparison
Open Charts RARE vs RVMDBanner chart's image
Ultragenyx Pharmaceutical
Price$35.13
Change-$0.24 (-0.68%)
Volume$12.94K
Capitalization3.3B
Revolution Medicines
Price$32.88
Change-$1.72 (-4.97%)
Volume$22.61K
Capitalization6.43B
RARE vs RVMD Comparison Chart
Loading...
RARE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RVMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RARE vs. RVMD commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RARE is a Hold and RVMD is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (RARE: $35.37 vs. RVMD: $34.60)
Brand notoriety: RARE and RVMD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RARE: 80% vs. RVMD: 274%
Market capitalization -- RARE: $3.3B vs. RVMD: $6.11B
RARE [@Biotechnology] is valued at $3.3B. RVMD’s [@Biotechnology] market capitalization is $6.11B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RARE’s FA Score shows that 0 FA rating(s) are green whileRVMD’s FA Score has 0 green FA rating(s).

  • RARE’s FA Score: 0 green, 5 red.
  • RVMD’s FA Score: 0 green, 5 red.
According to our system of comparison, RVMD is a better buy in the long-term than RARE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RARE’s TA Score shows that 4 TA indicator(s) are bullish while RVMD’s TA Score has 4 bullish TA indicator(s).

  • RARE’s TA Score: 4 bullish, 4 bearish.
  • RVMD’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both RARE and RVMD are a good buy in the short-term.

Price Growth

RARE (@Biotechnology) experienced а -6.87% price change this week, while RVMD (@Biotechnology) price change was -8.27% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.57%. For the same industry, the average monthly price growth was -10.69%, and the average quarterly price growth was -14.76%.

Reported Earning Dates

RARE is expected to report earnings on May 01, 2025.

RVMD is expected to report earnings on May 12, 2025.

Industries' Descriptions

@Biotechnology (-8.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RVMD($6.43B) has a higher market cap than RARE($3.3B). RARE YTD gains are higher at: -15.926 vs. RVMD (-20.896). RARE has higher annual earnings (EBITDA): -469M vs. RVMD (-677.7M). RVMD has more cash in the bank: 2.29B vs. RARE (610M). RARE has less debt than RVMD: RARE (40.3M) vs RVMD (136M). RARE has higher revenues than RVMD: RARE (560M) vs RVMD (0).
RARERVMDRARE / RVMD
Capitalization3.3B6.43B51%
EBITDA-469M-677.7M69%
Gain YTD-15.926-20.89676%
P/E RatioN/AN/A-
Revenue560M0-
Total Cash610M2.29B27%
Total Debt40.3M136M30%
FUNDAMENTALS RATINGS
RARE: Fundamental Ratings
RARE
OUTLOOK RATING
1..100
55
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
87
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RARERVMD
RSI
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
72%
MACD
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 11 days ago
79%
Bullish Trend 18 days ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
79%
Bearish Trend 3 days ago
77%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Ad is loading...
RARE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RVMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BRWJX23.020.22
+0.96%
MFS Blended Research Growth Eq I
AWSHX61.920.27
+0.44%
American Funds Washington Mutual A
ABCCX11.890.04
+0.34%
American Beacon Balanced C
SAGCX30.44N/A
N/A
ClearBridge Growth C
HMVSX16.83N/A
N/A
Hartford MidCap Value R4

RVMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, RVMD has been loosely correlated with IDYA. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if RVMD jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RVMD
1D Price
Change %
RVMD100%
+2.91%
IDYA - RVMD
47%
Loosely correlated
+10.70%
ERAS - RVMD
46%
Loosely correlated
+4.56%
KYMR - RVMD
46%
Loosely correlated
+4.46%
CRNX - RVMD
45%
Loosely correlated
+2.51%
RYTM - RVMD
44%
Loosely correlated
+3.92%
More